The ingredient is derived from the heat-killed, non-viable strain Clostridium tyrobutyricum (ASM19) and has secured a "No Questions" letter from the U.S. Food and Drug Administration regarding its GRAS status. Because the postbiotic is non-viable, it remains stable at room temperature and withstands harsh manufacturing processes like UHT treatment, which often degrade live cultures. With a typical inclusion rate of 200 mg per serving, the product aims to simplify formulation while providing a scientific profile that includes selective activation of TLR2, TLR5, and NOD2 receptors.
To accelerate the commercial expansion of this platform, the company has appointed Michael Bush as Co-Chairman of the Board. Bush, who previously led the probiotic brand Ganeden, noted that the ingredient's stability provides a distinct advantage in a crowded microbiome market. Superbrewed Food, led by CEO Bryan Tracy, is now offering commercial-scale supply and formulation support to brands looking to integrate the postbiotic into consumer goods.

Comments (0)
No comments yet. Be the first!